Miracor Medical Raises €24M in Series E Funding
Miracor Medical, the Belgian medical equipment developer, has raised €24M in a Series E funding round to advance its PiCSO clinical study programme, and for commercialization in Europe
clinical trials
23andMe and GSK start clinical trials for cancer drug
A collaboration between 23andMe and GSK is using genetic profiling for drug discovery
Evidation raises $45 million Series D
Evidation Health has closed a $45 million Series D financing round, led by B Capital Group. Marwaha joins as Chief Commercial Officer.
BioPharma Ledger brings blockchain to clinical trials
ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix
Deep Lens raises $14 million to accelerate clinical trial recruitment
Deep Lens, an AI-enabled clinical trial recruitment platform, has closed a $14 million Series A round led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.
TriNetX closes $40 million Series D for global expansion and product development
TriNetX, a clinical research network, has closed its Series D investment round of $40 million led by Merck GHIF. The funding will be used for international expansion and product development.
Gustave Roussy Institut to use blockchain for data in cancer drug trials
The Gustave Roussy Institut, a cancer centre in France, is to deploy blockchain in data-sharing applications for oncology research. The technology will be built in partnership with Embleema, a developer of a healthcare blockchain network, and will be used to improve transparency, patient safety and patient engagement in clinical trials.
AI drug trials to scale up in 2019
Predictions are two a penny at this time of year, and no one will hold those who make the predictions to account. Tractica, a market intelligence agency, has put out a white paper with predictions on Artificial Intelligence in 2019. Amongst them is an expectation of advancement in AI-enabled drug trials.